[Progress in diagnosis and therapy for Parkinson's disease].
Mizuno
Yoshikuni
Y
D018680:Cholinergic Antagonists / Q000008:administration & dosage; D018491:Dopamine Agonists / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005799:Genes, Dominant; D005808:Genes, Recessive; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects; D008025:Ligases / Q000235:genetics; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000235:genetics; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D051843:Synucleins; D044767:Ubiquitin-Protein Ligases; D016875:tau Proteins / Q000235:genetics
D018680:Cholinergic Antagonists; D018491:Dopamine Agonists; D009419:Nerve Tissue Proteins; D051843:Synucleins; D016875:tau Proteins; D007980:Levodopa; D044767:Ubiquitin-Protein Ligases; C111567:parkin protein; D008025:Ligases